> 首页 > 产品 > 一抗 > 基因重组 > Anti-glycoprotein (GP) IIb/IIIa Reference Antibody (Abciximab)

Anti-glycoprotein (GP) IIb/IIIa Reference Antibody (Abciximab)

Recombinant Antibody

Anti-glycoprotein (GP) Iib / IIIa Reference Antibody (Abciximab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-glycoprotein (GP) Iib / IIIa Reference Antibody (Abciximab) is 99.7%, determined by SEC-HPLC.
Anti-glycoprotein (GP) IIb/IIIa Reference Antibody (Abciximab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-glycoprotein (GP) IIb/IIIa Reference Antibody (Abciximab) is 98.8%, determined by SEC-HPLC.
Immobilized Human Integrin alpha 2b beta 3(ITGAIIb&ITGB3) Heterodimer Protein, His Tag Free, It’s target at 2 µg/mL can bind Abciximab, EC50= 0.003129 µg/mL.

产品详情
实验流程

Product Information
Application Applications Legend: E=ELISA WB=Western Blotting IHC=Immunohistochemistry IHC-P=Immunohistochemistry (Paraffin) IP=Immunoprecipitation IF=Immunofluorescence IC=Immunochemistry ICC=Immunocytochemistry FC=Flow Cytometry DB=Dot Blot	Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Reactivity	Human
Clonality	Monoclonal
Isotype	Fab-IgG1-CH1
Calculated MW	47 KDa

Additional Information
Target/Specificity	glycoprotein (GP) IIb/IIIa
Endotoxin	< 0.001EU/ µg,determined by LAL method.
Conjugation	Unconjugated
Expression system	CHO
Format	Purified monoclonal antibody supplied in PBS, pH6.0, without preservative.This antibody is purified through a protein A column.

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Research Areas

Application Protocols

Provided below are standard protocols that you may find useful for product applications.

Western Blot Protocol

Blocking Peptides Protocol

Dot Blot Protocol

Immunohistochemistry Protocol

Immunofluorescence Protocol

Immunoprecipitation Protocol

Flow Cytomety Protocol

Cell Culture Protocol